Stock Snapshot
| Table Header | Table Header |
|---|---|
| Company | Johnson & Johnson |
| Sector | Healthcare |
| Theme | Pharma & Medical Technology |
| Business Model | Development and marketing of innovative pharmaceuticals and medical technology |
| ISIN | US4781601046 |
| Market Capitalization | approx. USD 616.0 billion |
| UMBRELLA Status | Active |
UMBRELLA History
The key milestones of Johnson & Johnson within the UMBRELLA Strategy.
September 22, 2026
↓
Reduction
Healthcare weighting reduced
October 2, 2026
↓
Reduction
Position reduced toward 9%
October 6, 2026
↓
Reduction
Position reduced further
Latest Developments
↓
Reduction
October 6, 2026
Position reduced further
The weighting was reduced from approximately 8.9% to 6.3% – a reduction of around 29% compared with the previous position size.
↓
Reduction
October 2, 2026
Position reduced toward 9%
↓
Reduction
September 22, 2026
Healthcare weighting reduced
Following strong performance, a larger portion of the position was sold for the first time.